| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 442.82B | 247.57B | 218.91B | 277.24B | 207.61B | 233.93B |
| Gross Profit | 29.38B | 23.15B | 22.75B | 25.76B | 21.72B | 22.36B |
| EBITDA | 27.57B | 17.11B | 16.08B | 21.95B | 19.53B | 15.52B |
| Net Income | 15.77B | 10.04B | 11.63B | 12.64B | 11.90B | 10.34B |
Balance Sheet | ||||||
| Total Assets | 217.91B | 200.28B | 175.01B | 179.99B | 171.53B | 161.89B |
| Cash, Cash Equivalents and Short-Term Investments | 68.62B | 59.56B | 86.91B | 70.75B | 63.49B | 70.77B |
| Total Debt | 10.17B | 11.60B | 11.41B | 12.70B | 12.53B | 12.35B |
| Total Liabilities | 71.46B | 59.96B | 40.14B | 53.24B | 51.99B | 52.64B |
| Stockholders Equity | 146.45B | 140.32B | 134.87B | 126.75B | 119.53B | 109.25B |
Cash Flow | ||||||
| Free Cash Flow | 3.22B | -24.49B | 24.19B | 17.95B | -5.05B | 9.93B |
| Operating Cash Flow | 9.70B | -18.23B | 26.93B | 20.77B | -1.23B | 12.59B |
| Investing Cash Flow | -3.17B | -5.93B | -8.35B | -9.85B | -3.06B | -2.36B |
| Financing Cash Flow | -8.66B | -5.31B | -7.94B | -7.44B | -3.75B | -3.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥3.14T | 7.80 | 10.06% | 1.21% | 10.52% | 60.75% | |
75 Outperform | ¥13.15B | 10.63 | ― | 3.02% | 3.43% | 3.75% | |
75 Outperform | ¥184.43B | 16.57 | ― | 1.53% | 3.37% | 21.35% | |
72 Outperform | ¥137.78B | 3.86 | 8.07% | 2.64% | 79.29% | 35.48% | |
72 Outperform | ¥8.82T | 26.86 | 32.32% | 0.91% | 27.53% | 137.34% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥50.63B | -60.12 | ― | 5.01% | -32.74% | -117.06% |